The Cable: AstraZeneca Vaccine and Credit Suisse CEO (Podcast)

from The Cable · host Bloomberg News

Guy Johnson touched on a clinical trial out of the United States showing AstraZeneca's vaccine is 79 percent effective in preventing Covid-19. Lockdowns across Europe intesify and vaccine-roll out lags behind. We hear from Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli, Bloomberg’s Chad Thomas, Executive VP of AstraZeneca's BioPharmaceuticals Unit, Ruud Dobber, Sharron Bell, Goldman Sachs Global Investment Research Equity Strategist and Credit Suisse CEO Thomas Gottstein.

Episode metadata supplied by the publisher feed · Published Mar 22, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

The Cable: AstraZeneca Vaccine and Credit Suisse CEO (Podcast)

0:00 43:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Cable?

This episode is 43 minutes long.

When was this The Cable episode published?

This episode was published on March 22, 2021.

Can I download this The Cable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!